Re: Daily Dark Chocolate Consumption Modifies the Metabolism of Healthy Humans
Martin F-PJ, Rezzi S, Peré-Trepat E, et al. Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects. J Proteome Res.. October 7, 2009: [epub ahead of print] doi: 10.1021/pr900607v.
The metabolic phenotype of
humans is influenced by dietary preferences, lifestyle characteristics, and
genetics, and these factors help determine health status and the likelihood of
disease development. Dietary preferences are influenced by many biological and
behavioral processes, which integrate factors such as satiety, psychological
perception, and the metabolic effects of foods. One of the greatest challenges
in the field of nutrition is the classification of metabolic interactions
between complex food matrices in an effort to understand their role in human disease
processes.
The
metabolic phenotype of humans is influenced by dietary preferences, lifestyle
characteristics, and genetics, and these factors help determine health status
and the likelihood of disease development. Dietary preferences are influenced
by many biological and behavioral processes, which integrate factors such as
satiety, psychological perception, and the metabolic effects of foods. One of
the greatest challenges in the field of nutrition is the classification of
metabolic interactions between complex food matrices in an effort to understand
their role in human disease processes.
Several
studies have demonstrated the potential health implications of the various
constituents of dark chocolate (Theobroma
cacao), but rarely of chocolate as a "whole product." Cocoa is
rich in flavonoids (e.g., epicatechin, catechin, and their oligomers), which
have been shown to improve insulin sensitivity and glucose tolerance and to
have cardiovascular health benefits, i.e., reductions in blood pressure,
improvements in endothelial function, and decreases in thrombosis, oxidation,
and inflammation. Cocoa
also contains theobromine, which reduces blood pressure; phenylethylamine, a
neurotransmitter; and N-oleoyl- and N-linoleoyl-ethanolamine, which slows
the breakdown rate of the brain neurotransmitter anandamide. Despite evidence
of the health benefits of cocoa consumption, the mechanisms of action of the
bioactive components of cocoa at the molecular level are poorly understood. The
objective of the present study was to use metabonomics (the metabolic response of living systems to pathophysiologic
stresses or genetic modification) to evaluate the response of
free-living adults to daily chocolate consumption.
Thirty
healthy men (n = 11) and women (n = 19) aged 18-35 years were enrolled in this
randomized parallel study, which was conducted by TNO Quality of Life (the Netherlands).
The participants were requested to avoid consuming chocolate and
chocolate-containing products for 8 days before the study began and then were
divided into either a low-anxiety or a high-anxiety group based on their
responses to a validated psychological questionnaire—the State-Trait Anxiety
Inventory test. Both groups consumed 20 g of chocolate (Noir Intense; 74% cocoa
solids; Nestlé; Amsterdam, Netherlands) twice daily for 2 weeks as a midmorning
and midafternoon snack for a total daily dose of 40 g. Fasting blood samples
and morning spot urine samples were collected on day 1 (before intervention)
and on days 8 and 15 (after intervention). The plasma and urine samples were
subjected to nuclear magnetic resonance (NMR)- and mass spectrometry (MS)-based
metabonomic analyses to determine global changes in metabolic profiles. Partial
least squares (PLS) and orthogonal PLS discriminant analyses were used for
classification purposes.
NMR and MS
analyses detected a wide range of amino acids, organic acids, ketone bodies,
sugars, osmolytes, saturated and unsaturated fatty acids, and triglycerides in
plasma samples and of ketone bodies, organic acids, amino acids, and aromatic
metabolites in urine samples. NMR and MS data indicated statistically
significant time-dependent changes after dark chocolate consumption, e.g., a
reduction in the urinary excretion of the stress hormones cortisol and
catecholamines and partial normalization of stress-related differences in indicators
of energy metabolism (glycine, trans-aconitate,
proline, citrate, and b-alanine) and in the levels of
hippurate and p-cresol sulfate from
microbial metabolism in the gut. MS-based metabolic profiling showed that the
metabolic effects induced by chocolate consumption were statistically
significant only in subjects who were classified with high-anxiety. Compared
with low-anxiety subjects, MS-based data showed a pre-intervention metabolic
signature of higher urinary concentrations of glycine, 3-methoxytyrosine, b-alanine,
proline, 3,4-dihydroxyphenylalanine, and adrenaline, and lower levels of p-cresol sulfate and aconitate in
high-anxiety subjects. Compared with low-anxiety subjects, NMR-based data
showed higher urinary excretions of hippurate, glycine, and citrate and lower
levels of methyl-succinate and trans-aconitate in the high-anxiety subjects. In
plasma, high-anxiety subjects tended to have higher levels of choline and lower
levels of glycine and glutamine than in low-anxiety subjects. These levels in
high-anxiety subjects showed a trend toward low-anxiety levels, a normalization
of metabolic profiles, following chocolate consumption of 2 weeks.
The
metabolic profiles in urine and plasma indicated greater interindividual
differences than intraindividual differences, which point to the strong
influence of lifestyle and genetic factors on individual metabolic phenotypes.
The authors conclude that the results of this study provide "strong
evidence" that the daily consumption of 40 g of dark chocolate for 2 weeks
is sufficient to modify the metabolism of free-living and healthy human
subjects, as per variation in both the host and gut microbial metabolism. These
metabolic changes have "potential long-term consequences on human health
within only 2 weeks treatment" as evidenced by the reduction in stress
hormone levels and in the normalization of systemic stress metabolic
signatures. Thus, even subtle changes in dietary patterns will likely effect
changes in the metabolic status of free-living persons that may be associated
with long-term health consequences.